Eric Klein, MD, Glickman Urology & Kidney Institute, Cleveland, OH, highlights the hot topics in prostate cancer including new therapeutic targets and resistance to new -generation androgen-receptor antagonists. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).